PubRank

Latent HIV-1, Viral Suppress and Hope for HIV Cure

Clinical Trial ID NCT04938518

PubWeight™ 0.00‹?›

🔗 Visit the ClinicalTrials.gov page for NCT04938518

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Enhanced CD4+ T-cell recovery with earlier HIV-1 antiretroviral therapy. N Engl J Med 2013 4.26
2 Enhanced culture assay for detection and quantitation of latently infected, resting CD4+ T-cells carrying replication-competent virus in HIV-1-infected individuals. Methods Mol Biol 2005 2.99
3 Viremia and drug resistance among HIV-1 patients on antiretroviral treatment: a cross-sectional study in Soweto, South Africa. AIDS 2010 2.33
4 2014 Update of the drug resistance mutations in HIV-1. Top Antivir Med 2014 2.22
5 Low lopinavir plasma or hair concentrations explain second-line protease inhibitor failures in a resource-limited setting. J Acquir Immune Defic Syndr 2011 1.98
6 Quantification of HIV-1 latency reversal in resting CD4+ T cells from patients on suppressive antiretroviral therapy. Proc Natl Acad Sci U S A 2014 1.96
7 High rates of survival, immune reconstitution, and virologic suppression on second-line antiretroviral therapy in South Africa. J Acquir Immune Defic Syndr 2010 1.86
8 A universal real-time PCR assay for the quantification of group-M HIV-1 proviral load. Nat Protoc 2008 1.60
9 No effect of raltegravir intensification on viral replication markers in the blood of HIV-1-infected patients receiving antiretroviral therapy. J Acquir Immune Defic Syndr 2012 1.39
10 Plasma viremia and cellular HIV-1 DNA persist despite autologous hematopoietic stem cell transplantation for HIV-related lymphoma. J Acquir Immune Defic Syndr 2013 1.34
11 Designing and Interpreting Limiting Dilution Assays: General Principles and Applications to the Latent Reservoir for Human Immunodeficiency Virus-1. Open Forum Infect Dis 2015 1.08
12 Understanding HIV latency: the road to an HIV cure. Annu Rev Med 2015 1.07
13 ADAR1 is a novel multi targeted anti-HIV-1 cellular protein. Virology 2011 0.86
14 Incidence and predictors of first line antiretroviral regimen modification in western Kenya. PLoS One 2014 0.84
15 Durability of antiretroviral therapy and predictors of virologic failure among perinatally HIV-infected children in Tanzania: a four-year follow-up. BMC Infect Dis 2014 0.84
16 Changes to antiretroviral drug regimens during integrated TB-HIV treatment: results of the SAPiT trial. Antivir Ther 2013 0.80
17 Identification and characterization of HIV-1 latent viral reservoirs in peripheral blood. J Clin Microbiol 2014 0.77
18 Emergence of untreatable, multidrug-resistant HIV-1 in patients failing second-line therapy in Kenya. AIDS 2017 0.75
Next 100